

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding dominant... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1781/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1781" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view.">
            <meta name="og:description" content="Read the latest article version by Giulia Coarelli, Alexis Brice, Alexandra Durr, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="17234">
            <meta name="article-id" content="15788">
            <meta name="dc.title" content="Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view">
            <meta name="dc.description" content=" Abstract 
Spinocerebellar ataxias (SCAs) are rare types of cerebellar ataxia with a dominant mode of inheritance. To date, 47 SCA subtypes have been identified, and the number of genes implicated in SCAs is continually increasing. Polyglutamine (polyQ) expansion diseases 
( ATXN1 /SCA1, ATXN2 /SCA2, ATXN3 /SCA3, CACNA1A /SCA6, ATXN7 /SCA7, TBP /SCA17, and ATN1 /DRPLA) are the most common group of SCAs. No preventive or curative treatments are currently available, but various therapeutic approaches, including RNA-targeting treatments, such as antisense oligonucleotides (ASOs), are being developed. Clinical trials of ASOs in SCA patients are already planned. There is, therefore, a need to identify valid outcome measures for such studies. In this review, we describe recent advances towards identifying appropriate biomarkers, which are essential for monitoring disease progression and treatment efficacy. Neuroimaging biomarkers are the most powerful markers identified to date, making it possible to reduce sample sizes for clinical trials. Changes on brain MRI are already evident at the premanifest stage in SCA1 and SCA2 carriers and are correlated with CAG repeat size. Other potential biomarkers have also been developed, based on neurological examination, oculomotor study, cognitive assessment, and blood and cerebrospinal fluid analysis. Longitudinal studies based on multimodal approaches are required to establish the relationships between parameters and to validate the biomarkers identified.">
            <meta name="dc.subject" content="spinocerebellar ataxias, biomarkers, antisense oligonucleotides, clinical trials, neuroimaging ">
            <meta name="dc.creator" content="Coarelli, Giulia">
            <meta name="dc.creator" content="Brice, Alexis">
            <meta name="dc.creator" content="Durr, Alexandra">
            <meta name="dc.date" content="2018/11/12">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.15788.1">
            <meta name="dc.source" content="F1000Research 2018 7:1781">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="spinocerebellar ataxias">
            <meta name="prism.keyword" content="biomarkers">
            <meta name="prism.keyword" content="antisense oligonucleotides">
            <meta name="prism.keyword" content="clinical trials">
            <meta name="prism.keyword" content="neuroimaging ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/11/12">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1781">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.15788.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1781">
            <meta name="citation_title" content="Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view">
            <meta name="citation_abstract" content=" Abstract 
Spinocerebellar ataxias (SCAs) are rare types of cerebellar ataxia with a dominant mode of inheritance. To date, 47 SCA subtypes have been identified, and the number of genes implicated in SCAs is continually increasing. Polyglutamine (polyQ) expansion diseases 
( ATXN1 /SCA1, ATXN2 /SCA2, ATXN3 /SCA3, CACNA1A /SCA6, ATXN7 /SCA7, TBP /SCA17, and ATN1 /DRPLA) are the most common group of SCAs. No preventive or curative treatments are currently available, but various therapeutic approaches, including RNA-targeting treatments, such as antisense oligonucleotides (ASOs), are being developed. Clinical trials of ASOs in SCA patients are already planned. There is, therefore, a need to identify valid outcome measures for such studies. In this review, we describe recent advances towards identifying appropriate biomarkers, which are essential for monitoring disease progression and treatment efficacy. Neuroimaging biomarkers are the most powerful markers identified to date, making it possible to reduce sample sizes for clinical trials. Changes on brain MRI are already evident at the premanifest stage in SCA1 and SCA2 carriers and are correlated with CAG repeat size. Other potential biomarkers have also been developed, based on neurological examination, oculomotor study, cognitive assessment, and blood and cerebrospinal fluid analysis. Longitudinal studies based on multimodal approaches are required to establish the relationships between parameters and to validate the biomarkers identified.">
            <meta name="citation_description" content=" Abstract 
Spinocerebellar ataxias (SCAs) are rare types of cerebellar ataxia with a dominant mode of inheritance. To date, 47 SCA subtypes have been identified, and the number of genes implicated in SCAs is continually increasing. Polyglutamine (polyQ) expansion diseases 
( ATXN1 /SCA1, ATXN2 /SCA2, ATXN3 /SCA3, CACNA1A /SCA6, ATXN7 /SCA7, TBP /SCA17, and ATN1 /DRPLA) are the most common group of SCAs. No preventive or curative treatments are currently available, but various therapeutic approaches, including RNA-targeting treatments, such as antisense oligonucleotides (ASOs), are being developed. Clinical trials of ASOs in SCA patients are already planned. There is, therefore, a need to identify valid outcome measures for such studies. In this review, we describe recent advances towards identifying appropriate biomarkers, which are essential for monitoring disease progression and treatment efficacy. Neuroimaging biomarkers are the most powerful markers identified to date, making it possible to reduce sample sizes for clinical trials. Changes on brain MRI are already evident at the premanifest stage in SCA1 and SCA2 carriers and are correlated with CAG repeat size. Other potential biomarkers have also been developed, based on neurological examination, oculomotor study, cognitive assessment, and blood and cerebrospinal fluid analysis. Longitudinal studies based on multimodal approaches are required to establish the relationships between parameters and to validate the biomarkers identified.">
            <meta name="citation_keywords" content="spinocerebellar ataxias, biomarkers, antisense oligonucleotides, clinical trials, neuroimaging ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Giulia Coarelli">
            <meta name="citation_author_institution" content="Assistance Publique-Ho&#770;pitaux de Paris (AP-HP), Department of Neurology, Avicenne Hospital, Paris 13 University, Bobigny, 93000, France">
            <meta name="citation_author_institution" content="Institut du Cerveau et de la Moelle &eacute;pini&egrave;re, ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne University, Paris, 75013, France">
            <meta name="citation_author" content="Alexis Brice">
            <meta name="citation_author_institution" content="Assistance Publique-Ho&#770;pitaux de Paris (AP-HP), Genetic department, Piti&eacute;-Salp&ecirc;tri&egrave;re University Hospital, Paris, 75013, France">
            <meta name="citation_author_institution" content="Institut du Cerveau et de la Moelle &eacute;pini&egrave;re, ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne University, Paris, 75013, France">
            <meta name="citation_author" content="Alexandra Durr">
            <meta name="citation_author_institution" content="Institut du Cerveau et de la Moelle &eacute;pini&egrave;re, ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne University, Paris, 75013, France">
            <meta name="citation_author_institution" content="Assistance Publique-Ho&#770;pitaux de Paris (AP-HP), Genetic department, Piti&eacute;-Salp&ecirc;tri&egrave;re University Hospital, Paris, 75013, France">
            <meta name="citation_publication_date" content="2018/11/12">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1781">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.15788.1">
            <meta name="citation_firstpage" content="1781">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1781/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1781.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=17234 /> <input type=hidden id=articleId name=articleId value=15788 /> <input type=hidden id=xmlUrl value="/articles/7-1781/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1781-v1.xml"> <input type=hidden id=article_uuid value=1115b648-e99f-41fb-93f1-f9d8bba08461 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.15788.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.15788.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1781"
  },
  "headline": "Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view",
  "datePublished": "2018-11-12T14:10:47",
  "dateModified": "2018-11-12T14:10:47",
  "author": [
    {
      "@type": "Person",
      "name": "Giulia Coarelli"
    },    {
      "@type": "Person",
      "name": "Alexis Brice"
    },    {
      "@type": "Person",
      "name": "Alexandra Durr"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Abstract
Spinocerebellar ataxias (SCAs) are rare types of cerebellar ataxia with a dominant mode of inheritance. To date, 47 SCA subtypes have been identified, and the number of genes implicated in SCAs is continually increasing. Polyglutamine (polyQ) expansion diseases
(ATXN1/SCA1, ATXN2/SCA2, ATXN3/SCA3, CACNA1A/SCA6, ATXN7/SCA7, TBP/SCA17, and ATN1/DRPLA) are the most common group of SCAs. No preventive or curative treatments are currently available, but various therapeutic approaches, including RNA-targeting treatments, such as antisense oligonucleotides (ASOs), are being developed. Clinical trials of ASOs in SCA patients are already planned. There is, therefore, a need to identify valid outcome measures for such studies. In this review, we describe recent advances towards identifying appropriate biomarkers, which are essential for monitoring disease progression and treatment efficacy. Neuroimaging biomarkers are the most powerful markers identified to date, making it possible to reduce sample sizes for clinical trials. Changes on brain MRI are already evident at the premanifest stage in SCA1 and SCA2 carriers and are correlated with CAG repeat size. Other potential biomarkers have also been developed, based on neurological examination, oculomotor study, cognitive assessment, and blood and cerebrospinal fluid analysis. Longitudinal studies based on multimodal approaches are required to establish the relationships between parameters and to validate the biomarkers identified."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1781.html",
            "name": "Recent advances in understanding dominant spinocerebellar ataxias..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding dominant spinocerebellar ataxias... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=17234 data-id=15788 data-downloads="" data-views="" data-scholar="10.12688/f1000research.15788.1" data-recommended="" data-doi="10.12688/f1000research.15788.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1781/v1/pdf?article_uuid=1115b648-e99f-41fb-93f1-f9d8bba08461" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-15788-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-15788-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-15788-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Coarelli G, Brice A and Durr A. Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1781 (<a class=new-orange href="https://doi.org/10.12688/f1000research.15788.1" target=_blank>https://doi.org/10.12688/f1000research.15788.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-15788-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=15788 id=track-article-signin-15788 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/15788?target=/articles/7-1781.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17234 /> <input name=articleId type=hidden value=15788 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Giulia Coarelli<sup>1,2</sup>,&nbsp;</span><span class="">Alexis Brice<sup>2,3</sup>,&nbsp;</span><span class=""><a href="mailto:alexandra.durr@icm-institute.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Alexandra Durr</span></a><sup>2,3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Giulia Coarelli<sup>1,2</sup>,&nbsp;</span><span class="">Alexis Brice<sup>2,3</sup>,&nbsp;</span><span class=""><a href="mailto:alexandra.durr@icm-institute.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Alexandra Durr</span></a><sup>2,3</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 12 Nov 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.15788.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Assistance Publique-Ho&#770;pitaux de Paris (AP-HP), Department of Neurology, Avicenne Hospital, Paris 13 University, Bobigny, 93000, France<br/> <sup>2</sup> Institut du Cerveau et de la Moelle &eacute;pini&egrave;re, ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne University, Paris, 75013, France<br/> <sup>3</sup> Assistance Publique-Ho&#770;pitaux de Paris (AP-HP), Genetic department, Piti&eacute;-Salp&ecirc;tri&egrave;re University Hospital, Paris, 75013, France<br/> <p> <div class=margin-bottom> Giulia Coarelli <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Alexis Brice <br/> <span>Roles: </span> Supervision, Validation, Writing – Review & Editing </div> <div class=margin-bottom> Alexandra Durr <br/> <span>Roles: </span> Conceptualization, Supervision, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=41232-40146></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=41233-40148></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=41234-40147></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> <b>Abstract</b><br/> Spinocerebellar ataxias (SCAs) are rare types of cerebellar ataxia with a dominant mode of inheritance. To date, 47 SCA subtypes have been identified, and the number of genes implicated in SCAs is continually increasing. Polyglutamine (polyQ) expansion diseases<br/> (<i>ATXN1</i>/SCA1, <i>ATXN2</i>/SCA2, <i>ATXN3</i>/SCA3, <i>CACNA1A</i>/SCA6, <i>ATXN7</i>/SCA7,<i> TBP</i>/SCA17, and <i>ATN1</i>/DRPLA) are the most common group of SCAs. No preventive or curative treatments are currently available, but various therapeutic approaches, including RNA-targeting treatments, such as antisense oligonucleotides (ASOs), are being developed. Clinical trials of ASOs in SCA patients are already planned. There is, therefore, a need to identify valid outcome measures for such studies. In this review, we describe recent advances towards identifying appropriate biomarkers, which are essential for monitoring disease progression and treatment efficacy. Neuroimaging biomarkers are the most powerful markers identified to date, making it possible to reduce sample sizes for clinical trials. Changes on brain MRI are already evident at the premanifest stage in SCA1 and SCA2 carriers and are correlated with CAG repeat size. Other potential biomarkers have also been developed, based on neurological examination, oculomotor study, cognitive assessment, and blood and cerebrospinal fluid analysis. Longitudinal studies based on multimodal approaches are required to establish the relationships between parameters and to validate the biomarkers identified. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> spinocerebellar ataxias, biomarkers, antisense oligonucleotides, clinical trials, neuroimaging </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Alexandra Durr (<a href="mailto:alexandra.durr@icm-institute.org">alexandra.durr@icm-institute.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Alexandra Durr </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Coarelli G <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Coarelli G, Brice A and Durr A. Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1781 (<a href="https://doi.org/10.12688/f1000research.15788.1" target=_blank>https://doi.org/10.12688/f1000research.15788.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 12 Nov 2018, <b>7</b>(F1000 Faculty Rev):1781 (<a href="https://doi.org/10.12688/f1000research.15788.1" target=_blank>https://doi.org/10.12688/f1000research.15788.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 12 Nov 2018, <b>7</b>(F1000 Faculty Rev):1781 (<a href="https://doi.org/10.12688/f1000research.15788.1" target=_blank>https://doi.org/10.12688/f1000research.15788.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d12536e208>Introduction</h2><p class="" id=d12536e211>Spinocerebellar ataxias (SCAs) are a group of neurodegenerative diseases displaying autosomal dominant inheritance. To date, 47 SCA subtypes have been described, and 35 causal genes have been identified<sup><a href="#ref-1">1</a></sup>. SCAs are considered a rare group of cerebellar ataxias, with a mean prevalence of 2.7/100,000<sup><a href="#ref-2">2</a></sup>. Their most frequent forms are polyglutamine (polyQ) expansion diseases (<i>ATXN1</i>/SCA1, <i>ATXN2</i>/SCA2, <i>ATXN3</i>/SCA3, <i>CACNA1A</i>/SCA6, <i>ATXN7</i>/SCA7, <i>TBP</i>/SCA17, and <i>ATN1</i>/DRPLA)<sup><a href="#ref-3">3</a></sup>. These diseases manifest above a threshold number of CAG repeats, which is different for each gene. The same mutational mechanism is found in Huntington disease<sup><a href="#ref-4">4</a></sup> and in spinal bulbar muscular atrophy<sup><a href="#ref-5">5</a></sup>. Disease onset generally occurs between the ages of 20 and 40 years, and age at onset and CAG repeat expansion size are inversely correlated<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. Age at onset also displays variability due to interactions between polyQ genes, i.e. between the expanded allele and the alleles of normal repeat size in the other genes<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. The instability of expanded alleles results in genetic anticipation in successive generations<sup><a href="#ref-3">3</a></sup>. Unsteady gait and clumsiness are usually the first clinical symptoms at onset, followed by a progressive loss of the ability to walk. Cerebellar syndrome is often associated with extracerebellar signs (pyramidal syndrome, extrapyramidal syndrome, retinal degeneration, dementia, seizures, etc.)<sup><a href="#ref-3">3</a></sup>. There is currently no preventive or curative treatment, but different therapeutic approaches are being tested, including the use of disease-modifying compounds and therapeutic approaches, which are described below. However, in SCAs, the lack of sensitive biomarkers and the small number of patients to be included in clinical trials are a challenge for the statistical sample size estimation. Outcome measures providing information about treatment efficacy are vital, particularly for these genetic diseases that can be treated before the onset of symptoms. This review provides an overview of findings for biomarkers, recent results of clinical trials in SCA patients, and future perspectives for treatment.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12536e282>Natural history of spinocerebellar ataxias (SCA1, 2, 3, and 6)</h2><p class="" id=d12536e285>The natural history of SCA1, 2, 3, and 6 was established by the longitudinal European cohort study EUROSCA, which included 462 patients with at least one year of follow-up and a median of 49 months of observation<sup><a href="#ref-10">10</a></sup>. This study used the Scale for the Assessment and Rating of Ataxia (SARA), an accurate measurement of cerebellar dysfunction<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup> in SCA1, 2, 3, and 6 patients and premanifest individuals<sup><a href="#ref-13">13</a></sup>. The most severe disease turned out to be SCA1, with an annual progression of 2.11 on the 40-point SARA, followed by SCA3 (1.56 points), SCA2 (1.49 points), and SCA6 (0.8 points)<sup><a href="#ref-10">10</a></sup>. SCA1 has also been reported to have the most severe prognosis for progression in other studies, such as one in Europe<sup><a href="#ref-14">14</a></sup> and another conducted by the North American consortium (the Clinical Research Consortium for Spinocerebellar Ataxias)<sup><a href="#ref-15">15</a></sup>. This may be because of motoneuron involvement, which, particularly in this form, leads to bulbar dysfunction and, thus, to respiratory and swallowing failure<sup><a href="#ref-16">16</a></sup>. These results are consistent with 10-year survival, which is lowest for SCA1 patients, intermediate for SCA2 and SCA3, and highest for SCA6 patients<sup><a href="#ref-17">17</a></sup>. A high SARA score has also been identified as one of the strongest risk factors for death in all subtypes. Other associated risk factors include dysphagia for SCA1, longer CAG length in pathologic allele for SCA2, and dystonia and interaction between age and CAG length in SCA3<sup><a href="#ref-17">17</a></sup>. The Composite Cerebellar Functional Severity (CCFS) score is another quantitative score for assessing cerebellar ataxia that has been validated in adults and children<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. This score is calculated from scores for two tasks for the dominant hand—the nine-hole pegboard test and the click test—and is age dependent and available from an open source (<a target=xrefwindow href="https://icm-institute.org/en/tutorial-for-making-ccfs-board/" id=d12536e334>https://icm-institute.org/en/tutorial-for-making-ccfs-board/</a>). In a study on Friedreich ataxia and SCA1, 2, 3, and 7 patients, SARA and CCFS scores were higher in SCAs than in Friedreich ataxia after adjustment for disease duration, revealing a slower progression in Friedreich ataxia than in SCAs. Considering each SCA subtype separately, SCA2 and SCA1 patients had higher CCFS scores than did patients with other subtypes, despite an absence of difference in SARA scores<sup><a href="#ref-20">20</a></sup>, probably because of the more accentuate cerebellar syndrome.</p><p class="" id=d12536e343>Based on SARA score progression, the EUROSCA study identified, for each genotype, the sample sizes required to detect a 50% decrease in SARA score progression in a two-arm clinical trial lasting one year: 142 patients for SCA1, 172 for SCA2, 202 for SCA3, and 602 for SCA6<sup><a href="#ref-10">10</a></sup>. These are large numbers of patients for such rare diseases, making it necessary to carry out clinical trials at an international level. Additional biomarkers are required to overcome this problem. Furthermore, these dominantly inherited cerebellar ataxias have very different progression profiles, as shown in <a href="#f1">Figure 1</a>. Given the progressive nature of the disease and the sample sizes required, biomarkers are very important and essential.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/17234/61c3ad7a-95ff-4cf2-bcde-58d60b002ff0_figure1.gif"><img alt="61c3ad7a-95ff-4cf2-bcde-58d60b002ff0_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/17234/61c3ad7a-95ff-4cf2-bcde-58d60b002ff0_figure1.gif"></a><div class=caption><h3>Figure 1. Progression and severity profiles in cerebellar ataxias by underlying etiology</h3><p id=d12536e363>Multisystem atrophy (MSA) is a rapidly progressing non-monogenic alpha-synucleinopathy. It is the most severe of these diseases, followed by polyglutamine (polyQ) spinocerebellar ataxias (SCAs), such as <i>ATXN1</i>/SCA1, <i>ATXN2</i>/SCA2, <i>ATXN3</i>/SCA3, <i>CACNA1A</i>/SCA6, <i>ATXN7</i>/SCA7, <i>TBP</i>/SCA17, and <i>ATN1</i>/DRPLA. Very different profiles are present in the forms because of missense mutations in channel genes (<i>CACNA1A</i>, <i>KCND3</i>, <i>KCNC3</i>, and <i>KCNA1)</i>.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12536e407>Biomarkers</h2><div class=section><a name=d12536e410 class=n-a></a><h3 class=section-title>Neuroimaging biomarkers</h3><p class="" id=d12536e415>The most powerful biomarkers identified to date are derived from neuroimaging examinations. Specific patterns of brain atrophy have been described <i>in vivo</i> in polyQ SCAs<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup> and confirmed in post-mortem studies<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>. Changes in brain MRI findings are already evident at the premanifest stage in SCA1 and SCA2 carriers in the form of losses of gray matter from the cerebellum and brainstem. In SCA2 carriers only, an additional decrease in brainstem volume relative to non-carriers has also been reported<sup><a href="#ref-13">13</a></sup>. A recent case-control study on a Cuban-German cohort of premanifest and manifest SCA2 carriers reported remarkable decreases in cerebellum and pontine volume and in the anteroposterior diameter of the pontine brainstem. A negative correlation was found between CAG repeat size and brainstem and cerebellum volume in premanifest individuals<sup><a href="#ref-25">25</a></sup>. Cerebellar and pons atrophy was more pronounced in manifest patients<sup><a href="#ref-25">25</a></sup>, representing a potential outcome measure. By contrast, midbrain and medulla volumes did not differ significantly between the preclinical and clinical stages<sup><a href="#ref-25">25</a></sup>. In SCA2, white matter alterations in the parietal lobe and anterior corona radiata (detected by fractional anisotropy), and in the cerebellum and middle cerebellar peduncle (detected by mean diffusivity), were found to be correlated with SARA scores, leading the authors of the report concerned to suggest that connections between the motor and sensory integration areas might be impaired<sup><a href="#ref-26">26</a></sup>. However, with the exception of rare follow-up studies<sup><a href="#ref-21">21</a>,<a href="#ref-27">27</a></sup>, only cross-sectional brain MRI studies have been performed to date. Longitudinal studies will be required to establish the rate of progression of cerebellar and brainstem atrophy.</p><p class="" id=d12536e463>Cervical spinal cord atrophy has been proposed as a possible biomarker for SCA1, as it is correlated with SARA score, CAG repeat length, and disease duration<sup><a href="#ref-28">28</a></sup>. Indeed, the clinical presentation of this subtype can include pyramidal signs and it may, at early stages, mimic spastic paraplegia<sup><a href="#ref-29">29</a></sup>. Cervical spinal cord atrophy has also been identified as a potential biomarker for SCA3<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d12536e478>Neurochemical abnormalities can be detected by MRI spectroscopy (MRS), as demonstrated by the group headed by Gulin Oz<sup><a href="#ref-31">31</a></sup>. Decreases in N-acetylaspartate and glutamate levels reflect a loss of neurons, whereas increases in myoinositol serve as a marker of gliosis. N-acetylaspartate and N-acetylaspartylglutamate levels are significantly lower in the vermis and pons of SCA1, 2, 3, and 7 patients than in controls. Myoinositol levels are higher in SCA1, 2, and 3 patients than in controls. This neurochemical profile is particularly evident in SCA2 and SCA3 patients and is correlated with SARA score<sup><a href="#ref-32">32</a></sup>. Interestingly, multicenter acquisition of this technique has been validated<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d12536e493>Such alterations have been demonstrated by ultra-high-field MRS, even at the premanifest stage, with SCA2 patients showing the most compromised profile, followed by SCA1, SCA3, and SCA6 variant carriers<sup><a href="#ref-31">31</a></sup>.</p><p class="" id=d12536e501>Another recent neuroimaging technique applied to SCAs is functional MRI (fMRI) at rest<sup><a href="#ref-33">33 </a></sup>or during a task<sup><a href="#ref-34">34</a></sup>. This technique can be used to characterize circuitry reorganization, making it possible to identify specific patterns of cerebellar activation<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. Using this approach in the early phase of SCA3 disease, Duarte <i>et al</i>. discovered a reorganization of the motor network that could potentially serve as a biomarker<sup><a href="#ref-37">37</a></sup>. However, more detailed analyses of fMRI outcomes are required for future application.</p><p class="" id=d12536e526>Neuroimaging biomarkers are more powerful than clinical scores for the detection of disease progression. In a cohort of SCA1, 2, 3, and 7 patients, greater longitudinal effect size was detected for brain volumetry (&gt;1.2) than SARA and CCFS scores (&lt;0.8)<sup><a href="#ref-27">27</a></sup>. In conclusion, measures of pons and cerebellum atrophy seem to be the most promising biomarkers.</p></div><div class=section><a name=d12536e534 class=n-a></a><h3 class=section-title>Oculomotor biomarkers</h3><p class="" id=d12536e539>Oculomotor involvement is present at an early phase of SCA and is detectable even at premanifest stages as a higher rate of gaze-evoked nystagmus or other alterations, such as a square-wave jerk during central fixation, impaired vertical smooth pursuit, slow saccade, and a higher antisaccade error rate in SCA3 carriers than controls<sup><a href="#ref-13">13</a>,<a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. These alterations have been studied in detail in SCA2 patients, all of whom present specific oculomotor abnormalities (slow horizontal saccades up to saccade paresis)<sup><a href="#ref-40">40</a></sup>. Preclinical SCA2 carriers present a reduced saccade velocity and antisaccade task errors<sup><a href="#ref-41">41</a></sup>.</p><p class="" id=d12536e560>Moreover, in manifest and premanifest SCA2 carriers, both the progression of oculomotor impairment and the slowing of horizontal saccade velocity are correlated, respectively, with CAG repeat size<sup><a href="#ref-42">42</a></sup> and pontine atrophy<sup><a href="#ref-25">25</a></sup>. The annual decrease in saccade velocity and saccade accuracy and an increase in saccade latency may soon be used as biomarkers. This correlation between saccade measurements and other parameters, such as brain MRI and/or cognitive assessment, may make it possible to reduce sample size in future trials<sup><a href="#ref-42">42</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12536e579>Biological biomarkers</h2><p class="" id=d12536e582>No biological biomarkers for SCAs have yet been identified, a situation contrasting with other neurodegenerative diseases, such as Alzheimer’s disease and frontotemporal dementia. There is, therefore, a need to search for blood or cerebrospinal fluid (CSF) biomarkers of these diseases. In addition to guiding diagnostic process, biomarkers may be of use in clinical management if linked to disease progression.</p><p class="" id=d12536e585>In this respect, several recent studies in patients with SCA3, the most frequent SCA subtype, have yielded promising results. <i>SIRT1</i> encodes sirtuin-1, an NAD<sup>+</sup>-dependent deacetylase involved in several cellular functions, including chromatin modulation, the cell cycle, apoptosis, and autophagy regulation in response to DNA damage. SIRT1 mRNA levels are lower in SCA3 mice than in wild-type mice and are also low in the fibroblasts of SCA3 patients<sup><a href="#ref-43">43</a></sup>. In SCA3 mice, the rescue of SIRT1 by caloric restriction or the administration of resveratrol induces motor improvement and neuropathological changes, such as a decrease in neuroinflammation and reactive gliosis with an activation of autophagy<sup><a href="#ref-43">43</a></sup>. <i>SIRT1</i> overexpression has been shown to activate autophagy and thus to induce higher levels of mutant protein clearance. For these reasons, resveratrol may be a useful neuroprotective drug, as shown in some assays in <i>Drosophila</i> models of SCA3<sup><a href="#ref-44">44</a></sup> and in the rat 3-acetylpyridine-induced cerebellar ataxia model<sup><a href="#ref-45">45</a></sup>. Other studies have also demonstrated an imbalance between autophagy and apoptosis in SCA3. For example, an increase has been reported in the levels of <i>BECN1</i>, encoding the proautophagic Beclin 1 protein<sup><a href="#ref-46">46</a></sup>, and BCL2/BAX ratio has been shown to be lower in pre-ataxic SCA3 carriers than in controls<sup><a href="#ref-47">47</a></sup>, enhancing apoptotic processes.</p><p class="" id=d12536e628>Oxidative stress has been implicated in several neurodegenerative disorders, and SCA3 patients have been shown to produce abnormally large amounts of reactive oxygen species<sup><a href="#ref-48">48</a></sup>. This phenomenon results from a decrease in antioxidant capacity: both superoxide dismutase and glutathione peroxidase (GPx) activities are lower in symptomatic than in pre-symptomatic carriers<sup><a href="#ref-49">49</a></sup>. Moreover, the observed correlation of the decrease in GPx levels with disease severity suggests that GPx may be a reliable biomarker<sup><a href="#ref-49">49</a></sup>.</p><p class="" id=d12536e643>Cytokines have also been investigated as possible markers of SCA3. Indeed, enhanced inflammation has been linked to stronger staining for IL1B and IL6 and higher levels of activated microglia and reactive astrocytes in the brains of SCA3 patients<sup><a href="#ref-50">50</a></sup>. In a study on Brazilian SCA3 patients, no difference in cytokine levels was detected between 79 carriers and 43 controls. On the contrary, higher eotaxin levels were observed in asymptomatic carriers than in symptomatic carriers. It has been suggested that the levels of eotaxin released by astrocytes are inversely correlated with disease progression<sup><a href="#ref-51">51</a></sup>. In another cohort of SCA3 patients recruited in the Azores, lower IL6 mRNA levels, due to the presence of the IL6*C allele, were associated with an earlier age at onset than the presence of the IL6*G allele<sup><a href="#ref-52">52</a></sup>. In this study, the earlier age at onset (by about 10 years on average) resulted from the presence of the APOE*e2 allele in IL6*C carriers, probably because of additional decreases in the levels of other cytokines, such as IL1B and TNF, due to the presence of the APOE*e2 allele<sup><a href="#ref-53">53</a></sup>.</p><p class="" id=d12536e663>In a recent study, serum neurofilament light chain (Nfl) was identified as a powerful potential serum biomarker in polyQ SCAs<sup><a href="#ref-54">54</a></sup>. Neurofilaments are components of the neuron cytoskeleton, and their levels in the blood reflect damage to the axons of long fiber tracts<sup><a href="#ref-55">55</a></sup>. In Huntington disease, which is also a polyQ disease, a correlation between serum Nfl levels and disease severity (UHDRS, cognitive decline, brain atrophy) has been reported, even after adjustment for age and CAG repeat size<sup><a href="#ref-56">56</a></sup>. Nfl dosage is also useful for predicting disease onset in pre-symptomatic carriers and the progression of Huntington disease<sup><a href="#ref-56">56</a></sup>. In a study by Wilke <i>et al</i>., Nfl levels were higher in SCAs patients than in controls, particularly for SCA1 and SCA3<sup><a href="#ref-54">54</a></sup>. The CSF has been only briefly explored in SCAs. CSF Nfl levels are a potential diagnostic and prognostic biomarker for SCAs, as in amyotrophic lateral sclerosis<sup><a href="#ref-57">57</a></sup>. A study in SCA1, SCA2, and SCA6 patients evaluated α-synuclein, DJ-1, and glial fibrillary acidic protein levels in CSF. The levels of all of these proteins were higher in CSF from patients than in control CSF, but this difference was significant only for tau, the levels of which were significantly higher in SCA2 patients. No correlations were found for CAG repeat size, disease severity, and disease duration<sup><a href="#ref-58">58</a></sup>. It will be very interesting to determine polyQ protein levels in the CSF of SCA patients, as has been done already for Huntington disease.</p><div class=section><a name=d12536e698 class=n-a></a><h3 class=section-title>Cognition in spinocerebellar ataxias</h3><p class="" id=d12536e703>Cognitive impairment, of various degrees of severity, can occur in polyQ SCAs. It involves mostly the executive functions and verbal memory, as shown in one of the first cognitive studies to compare the profiles of SCA1, 2, and 3 patients<sup><a href="#ref-59">59</a></sup>. Cognitive decline was more prominent and rapid in SCA1 than in the other genotypes<sup><a href="#ref-59">59</a>–<a href="#ref-61">61</a></sup> and was associated with an increase in the incidence of depression<sup><a href="#ref-61">61</a></sup>. In another study, SCA2 patients were found to have more visuospatial and visuoperceptive deficits than SCA1 patients<sup><a href="#ref-62">62</a></sup>. In a recent study focusing on cognitive dysfunction in SCA6 patients, mild impairments of executive functions, mental flexibility, and visuospatial skills were found to be correlated with decreased resting-state connectivity in the frontoparietal network<sup><a href="#ref-63">63</a></sup>. These data support a role for the cerebellum in cognitive processes, given that the cerebellum is the principal cerebral structure affected and neuronal loss is less severe in SCA6 than in other polyQ diseases<sup><a href="#ref-23">23</a></sup>. The scales most widely used to assess dementia, such as the Mini-Mental State Examination or Montreal Cognitive Assessment, are not appropriate for the detection of cognitive impairment in SCA patients, who present a cerebellar cognitive affective/Schmahmann’s syndrome (CCAS)<sup><a href="#ref-64">64</a></sup>. This syndrome includes executive dysfunctions, spatial cognition difficulties, language deficits, and personality changes. A CCAS scale has recently been validated in a large cohort of cerebellar patients with acquired, genetic, or idiopathic cause and shown to have a sensitivity of 95% and a selectivity of 78% for CCAS diagnosis<sup><a href="#ref-64">64</a></sup>. This scale, which is easy and fast to administer, can be used for cognitive evaluation, which should be performed in longitudinal studies of patients.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12536e746>Genetic advances in spinocerebellar ataxias</h2><p class="" id=d12536e749>The number of genes implicated in SCAs has steadily increased over time. The last causal gene to have been identified, in SCA47 patients, is <i>PUM1,</i> encoding Pumilio1, a member of the PUMILIO/FBF RNA-binding protein family. The loss of <i>Pum1</i> led to an SCA1-like phenotype in mice by causing a 30–40% increase in wild-type Atxn1 protein levels in the cerebellum<sup><a href="#ref-65">65</a></sup>. These two proteins are functionally related: in SCA1 mice, the disease is more severe if one copy of <i>Pum1</i> is removed, whereas the motor phenotype of <i>Pum1-</i>heterozygous mice is improved by the removal of one copy of <i>Atxn1</i><sup><a href="#ref-65">65</a></sup>. Mutations of <i>PUM1</i> were reported by Gennarino <i>et al</i>. in 15 patients, with different ages at disease onset (5 months to 50 years) and phenotypic presentations. A 50% loss of the protein resulted in a severe infantile disease and a developmental syndrome called Pumilio1-associated developmental disability, ataxia, and seizure (PADDAS), whereas the loss of 25% of the protein caused Pumilio1-related cerebellar ataxia (PRCA), with a later onset and incomplete penetrance<sup><a href="#ref-66">66</a></sup>.</p><p class="" id=d12536e785>Using whole-exome sequencing (WES), Nibbeling <i>et al</i>. identified the genes associated with SCA46 and SCA45: <i>PLD3</i> and <i>FAT2</i>, respectively. These genes, which are strongly expressed in the cerebellum, cause pure adult-onset cerebellar ataxia. However, in some cases, SCA46 patients may present with a sensory neuropathy<sup><a href="#ref-67">67</a></sup>.</p><p class="" id=d12536e801>Genes encoding ion channels are frequently involved in dominant cerebellar ataxia: mutations of <i>CACNA1A</i> are the most frequent genetic cause of autosomal dominant cerebellar ataxia in patients negative for polyQ SCAs, followed by other channel-coding genes, such as <i>KCND3</i>, <i>KCNC3</i>, and <i>KCNA1</i><sup><a href="#ref-68">68</a></sup>. These genes predispose the patient to an earlier disease onset, intellectual deficiency, and slower disease progression<sup><a href="#ref-68">68</a></sup>. <i>CACNA1G</i> mutations, underlying SCA42<sup><a href="#ref-69">69</a></sup>, lead to a slowly progressive pure<sup><a href="#ref-70">70</a></sup> or complicated cerebellar ataxia associated with a spastic gait<sup><a href="#ref-69">69</a></sup>. Patients with earlier onset may also present facial dysmorphisms, microcephaly, digital abnormalities, and seizures<sup><a href="#ref-71">71</a></sup>.</p><p class="" id=d12536e843>Another channel gene implicated in SCA44 is <i>GRM1</i>, encoding the metabotropic glutamate receptor 1 (mGluR1) responsible for two phenotypic manifestations: adult-onset cerebellar ataxia in the presence of gain-of-function mutations and early onset ataxia with intellectual deficiency when associated with loss-of-function mutations<sup><a href="#ref-72">72</a></sup>.</p><p class="" id=d12536e854>The use of next-generation sequencing (NGS) techniques, such as WES, in everyday clinical practice has increased the diagnostic rate of complex neurological diseases<sup><a href="#ref-73">73</a>,<a href="#ref-74">74</a></sup>. The application of NGS in ataxia patients has revealed new SCA genes and improved our knowledge of the molecular pathways involved in cerebellar ataxia. It also affects the development of new therapeutic approaches: for example, elucidation of the role of mGluR1 in the excitability of Purkinje cells led to experiments modulating mGluR1 activity in SCA1 mice with drugs such as baclofen or the negative allosteric modulator JNJ16259685, both of which improved motor function<sup><a href="#ref-75">75</a>,<a href="#ref-76">76</a></sup>. As well, in a recent study by Bushart <i>et al</i>., the administration of potassium channel modulators induced improvement in SCA1 mice motor phenotype via electrophysiological changes<sup><a href="#ref-77">77</a></sup>; the authors also showed that chlorzoxazone and baclofen co-administration was well tolerated by SCA1 patients and should be considered as a promising approach for treating symptoms<sup><a href="#ref-77">77</a></sup>.</p><p class="" id=d12536e882>However, today, WES will not detect trinucleotide repeat disorders, mitochondrial DNA mutations, or large structural variants. Novel or <i>de novo</i> repeat expansions are still difficult to detect by short-read sequencing<sup><a href="#ref-78">78</a></sup>. Tandem repeats are usually discarded by NGS pipelines, but bioinformatics efforts will be made to detect them. Recently, a novel intronic expansion, a pentanucleotide-repeat in <i>SAMD12,</i> has been identified in familial myoclonic epilepsy<sup><a href="#ref-78">78</a></sup>. Long-read sequencing will probably allow one to identify more neurological repeat disorders.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12536e903>Therapeutic approaches in spinocerebellar ataxias</h2><p class="" id=d12536e906>Over the last few years, several disease-modifying treatments have been tested with different outcomes. The most beneficial molecules to date are riluzole and valproic acid, whereas other drugs, such as lithium carbonate, trimethoprim-sulfamethoxazole, or zinc, have no significant effect<sup><a href="#ref-79">79</a></sup>. A randomized placebo-controlled clinical trial in 40 SCA patients (SCA1, 2, 6, 8, and 10) and 20 Friedreich ataxia patients treated with riluzole (100 mg/day) for 12 months revealed a one-point improvement in SARA score in treated patients compared to the placebo group<sup><a href="#ref-80">80</a></sup>. The use of valproic acid (1,200 mg/day) in SCA3 patients resulted in a SARA score at 12 weeks lower than that obtained for patients on placebo<sup><a href="#ref-81">81</a></sup>. However, further trials are required to identify the genotype associated with a positive response to riluzole (ClinicalTrials.gov Identifier: NCT03347344).</p><p class="" id=d12536e921>Based on the hypothesis that one of the main omega-3 polyunsaturated fatty acids of the cerebellum, docosahexaenoic acid (DHA), is present at low levels in SCA38 patients owing to <i>ELOVL5</i> mutations, a clinical trial of DHA (600 mg/day) was performed<sup><a href="#ref-82">82</a></sup>. This drug improved SARA score at 16 weeks in a small group of SCA38 patients and it also increased cerebellar metabolism, as shown by a brain 18-fluorodeoxyglucose positron emission tomography scan at 40 weeks<sup><a href="#ref-82">82</a></sup>.</p><p class="" id=d12536e935>However, the most encouraging and innovative strategies developed to date are RNA-targeting therapies for polyQ SCAs, which have been validated in several mouse models<sup><a href="#ref-83">83</a>,<a href="#ref-84">84</a></sup>. These approaches mostly use antisense oligonucleotides (ASOs) to downregulate levels of the pathological polyQ protein. SCA2 mice treated with intrathecal ASOs display improvements in motor abilities, a recovery of Purkinje cell firing frequency, and lower levels of mutated ATXN2 protein<sup><a href="#ref-85">85</a></sup>. ASOs have also been administered to SCA3 mice and were found to be well tolerated and to decrease the production of mutated protein<sup><a href="#ref-86">86</a></sup>. A correlation was also found with electrophysiological changes in Purkinje cells<sup><a href="#ref-87">87</a></sup>. These treatments may be used in patients with polyQ SCAs at early stages of the disease, even before the onset of symptoms. The long-term effects of decreasing levels of wild-type and mutated proteins and of decreasing the levels of other polyQ proteins remain unclear. The use of allele-specific ASOs may be required<sup><a href="#ref-88">88</a></sup>. A therapeutic approach based on ASOs is already at an advanced stage of development for Huntington disease<sup><a href="#ref-89">89</a></sup>, and a phase 1A clinical trial in patients has yielded promising results<sup><a href="#ref-90">90</a></sup>. ASO-based treatments are also being used for spinal muscular atrophy, in a different context, to retain exon 7 and produce a full-length SMN protein, with promising results<sup><a href="#ref-91">91</a>,<a href="#ref-92">92</a></sup>.</p><p class="" id=d12536e977>The advent of disease-modifying treatments for SCAs, including ASOs, will require the rapid identification and validation of robust biomarkers of disease progression or processes for the assessment of treatment response.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12536e983>Conclusion</h2><p class="" id=d12536e986>This review summarizes recent clinical and genetic advances in dominant SCAs, including discoveries of novel SCAs, development of biomarkers, and therapeutic progress. The identification of biomarkers will be essential to demonstrate treatment efficacy. Future longitudinal studies based on multimodal approaches to elucidate the relationships between parameters will be required for the establishment of valid biomarkers. To date, gene suppression therapies are the most promising in polyQ SCAs, and clinical trials in the next few years are justified.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12536e992>Abbreviations</h2><p class="" id=d12536e995>ASO, antisense oligonucleotide; CCAS, cerebellar cognitive affective/Schmahmann’s syndrome; CCFS, Composite Cerebellar Functional Severity; CSF, cerebrospinal fluid; DHA, docosahexaenoic acid; fMRI, functional MRI; GPx, glutathione peroxidase; mGluR1, metabotropic glutamate receptor 1; MRS, MRI spectroscopy; Nfl, neurofilament light; NGS, next-generation sequencing; polyQ, polyglutamine; SARA, Scale for the Assessment and Rating of Ataxia; SCA, spinocerebellar ataxia; WES, whole-exome sequencing.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d12536e1 class=n-a></a><h2 class=main-title id=d12844>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d12536e1002 class=n-a></a><h2 class=main-title id=d12536e1004>Acknowledgments</h2><p class="" id=d12536e1007>We thank the patients’ associations for their continuous support of our research: Association Connaitre les Syndromes Cérébelleux, Association Strumpell-Lorrain, Association Française de l’Ataxie de Friedreich, and the Tom Wahlig Foundation.</p></div><div class=back-section><a name=d12536e1011 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d13162>References</h2><div class="section ref-list"><a name=d12536e1011 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d12536e1018 class=n-a></a>Online Mendelian inheritance in man. OMIM Baltimore, MD: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University. <a target=xrefwindow id=d12536e1020 href="https://omim.org/">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d12536e1029 class=n-a></a>Ruano L, Melo C, Silva MC, <i> et al.</i>: The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. <i>Neuroepidemiology.</i> 2014; <b>42</b>(3): 174–83. <a target=xrefwindow id=d12536e1040 href="http://www.ncbi.nlm.nih.gov/pubmed/24603320">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1043 href="https://doi.org/10.1159/000358801">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d12536e1052 class=n-a></a>Durr A: Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. <i>Lancet Neurol.</i> 2010; <b>9</b>(9): 885–94. <a target=xrefwindow id=d12536e1060 href="http://www.ncbi.nlm.nih.gov/pubmed/20723845">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1063 href="https://doi.org/10.1016/S1474-4422(10)70183-6">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d12536e1072 class=n-a></a>MacDonald ME, Ambrose CM, Duyao MP, <i> et al.</i>A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. <i>Cell.</i> 1993; <b>72</b>(6): 971–83. <a target=xrefwindow id=d12536e1083 href="http://www.ncbi.nlm.nih.gov/pubmed/8458085">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1086 href="https://doi.org/10.1016/0092-8674(93)90585-E">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d12536e1095 class=n-a></a>La Spada AR, Wilson EM, Lubahn DB, <i> et al.</i>: Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. <i>Nature.</i> 1991; <b>352</b>(6330): 77–9. <a target=xrefwindow id=d12536e1106 href="http://www.ncbi.nlm.nih.gov/pubmed/2062380">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1109 href="https://doi.org/10.1038/352077a0">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d12536e1119 class=n-a></a>Stevanin G, Dürr A, Brice A: Clinical and molecular advances in autosomal dominant cerebellar ataxias: From genotype to phenotype and physiopathology. <i>Eur J Hum Genet.</i> 2000; <b>8</b>(1): 4–18. <a target=xrefwindow id=d12536e1127 href="http://www.ncbi.nlm.nih.gov/pubmed/10713882">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1130 href="https://doi.org/10.1038/sj.ejhg.5200403">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d12536e1139 class=n-a></a>Orr HT, Zoghbi HY: Trinucleotide repeat disorders. <i>Annu Rev Neurosci.</i> 2007; <b>30</b>: 575–621. <a target=xrefwindow id=d12536e1147 href="http://www.ncbi.nlm.nih.gov/pubmed/17417937">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1150 href="https://doi.org/10.1146/annurev.neuro.29.051605.113042">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d12536e1159 class=n-a></a>Tezenas du Montcel S, Durr A, Bauer P, <i> et al.</i>: Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. <i>Brain.</i> 2014; <b>137</b>(Pt 9): 2444–55. <a target=xrefwindow id=d12536e1170 href="http://www.ncbi.nlm.nih.gov/pubmed/24972706">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1173 href="https://doi.org/10.1093/brain/awu174">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1177 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4132646">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d12536e1186 class=n-a></a>Tezenas du Montcel S, Durr A, Rakowicz M, <i> et al.</i>: Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. <i>J Med Genet.</i> 2014; <b>51</b>(7): 479–86. <a target=xrefwindow id=d12536e1197 href="http://www.ncbi.nlm.nih.gov/pubmed/24780882">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1200 href="https://doi.org/10.1136/jmedgenet-2013-102200">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1204 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4078703">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d12536e1213 class=n-a></a>Jacobi H, Du Montcel ST, Bauer P, <i> et al.</i>: Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. <i>Lancet Neurol.</i> 2015; <b>14</b>(11): 1101–8. <a target=xrefwindow id=d12536e1224 href="http://www.ncbi.nlm.nih.gov/pubmed/26377379">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1227 href="https://doi.org/10.1016/S1474-4422(15)00202-1">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d12536e1236 class=n-a></a>Schmitz-Hübsch T, du Montcel ST, Baliko L, <i> et al.</i>: Scale for the assessment and rating of ataxia: development of a new clinical scale. <i>Neurology.</i> 2006; <b>66</b>(11): 1717–20. <a target=xrefwindow id=d12536e1247 href="http://www.ncbi.nlm.nih.gov/pubmed/16769946">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1250 href="https://doi.org/10.1212/01.wnl.0000219042.60538.92">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d12536e1260 class=n-a></a>Schmitz-Hübsch T, Fimmers R, Rakowicz M, <i> et al.</i>: Responsiveness of different rating instruments in spinocerebellar ataxia patients. <i>Neurology.</i> 2010; <b>74</b>(8): 678–84. <a target=xrefwindow id=d12536e1271 href="http://www.ncbi.nlm.nih.gov/pubmed/20177122">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1274 href="https://doi.org/10.1212/WNL.0b013e3181d1a6c9">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718027129"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e1283 class=n-a></a>Jacobi H, Reetz K, du Montcel ST, <i> et al.</i>: Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. <i>Lancet Neurol.</i> 2013; <b>12</b>(7): 650–8. <a target=xrefwindow id=d12536e1294 href="http://www.ncbi.nlm.nih.gov/pubmed/23707147">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1297 href="https://doi.org/10.1016/S1474-4422(13)70104-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718027129">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d12536e1310 class=n-a></a>Monin ML, Tezenas du Montcel S, Marelli C, <i> et al.</i>: Survival and severity in dominant cerebellar ataxias. <i>Ann Clin Transl Neurol.</i> 2015; <b>2</b>(2): 202–7. <a target=xrefwindow id=d12536e1321 href="http://www.ncbi.nlm.nih.gov/pubmed/25750924">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1324 href="https://doi.org/10.1002/acn3.156">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1328 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4338960">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d12536e1337 class=n-a></a>Ashizawa T, Figueroa KP, Perlman SL, <i> et al.</i>: Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. <i>Orphanet J Rare Dis.</i> 2013; <b>8</b>: 177. <a target=xrefwindow id=d12536e1348 href="http://www.ncbi.nlm.nih.gov/pubmed/24225362">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1351 href="https://doi.org/10.1186/1750-1172-8-177">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1355 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3843578">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732629952"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e1364 class=n-a></a>Orengo JP, van der Heijden ME, Hao S, <i> et al.</i>: Motor neuron degeneration correlates with respiratory dysfunction in SCA1. <i>Dis Model Mech.</i> 2018; <b>11</b>(2): pii: dmm032623. <a target=xrefwindow id=d12536e1375 href="http://www.ncbi.nlm.nih.gov/pubmed/29419414">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1378 href="https://doi.org/10.1242/dmm.032623">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1382 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5894948">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732629952">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d12536e1395 class=n-a></a>Diallo A, Jacobi H, Cook A, <i> et al.</i>: Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study. <i>Lancet Neurol.</i> 2018; <b>17</b>(4): 327–34. <a target=xrefwindow id=d12536e1406 href="http://www.ncbi.nlm.nih.gov/pubmed/29553382">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1409 href="https://doi.org/10.1016/S1474-4422(18)30042-5">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d12536e1419 class=n-a></a>du Montcel ST, Charles P, Ribai P, <i> et al.</i>: Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. <i>Brain.</i> 2008; <b>131</b>(Pt 5): 1352–61. <a target=xrefwindow id=d12536e1430 href="http://www.ncbi.nlm.nih.gov/pubmed/18378516">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1433 href="https://doi.org/10.1093/brain/awn059">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d12536e1442 class=n-a></a>Filipovic Pierucci A, Mariotti C, Panzeri M, <i> et al.</i>: Quantifiable evaluation of cerebellar signs in children. <i>Neurology.</i> 2015; <b>84</b>(12): 1225–32. <a target=xrefwindow id=d12536e1453 href="http://www.ncbi.nlm.nih.gov/pubmed/25716360">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1456 href="https://doi.org/10.1212/WNL.0000000000001403">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d12536e1465 class=n-a></a>Tanguy Melac A, Mariotti C, Filipovic Pierucci A, <i> et al.</i>: Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements. <i>J Neurol Neurosurg Psychiatry.</i> 2018; <b>89</b>(6): 559–65. <a target=xrefwindow id=d12536e1476 href="http://www.ncbi.nlm.nih.gov/pubmed/29279305">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1479 href="https://doi.org/10.1136/jnnp-2017-316964">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d12536e1488 class=n-a></a>Reetz K, Costa AS, Mirzazade S, <i> et al.</i>: Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. <i>Brain.</i> 2013; <b>136</b>(Pt 3): 905–17. <a target=xrefwindow id=d12536e1499 href="http://www.ncbi.nlm.nih.gov/pubmed/23423669">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1502 href="https://doi.org/10.1093/brain/aws369">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d12536e1511 class=n-a></a>Mascalchi M, Diciotti S, Giannelli M, <i> et al.</i>: Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study. <i>PLoS One.</i> 2014; <b>9</b>(2): e89410. <a target=xrefwindow id=d12536e1522 href="http://www.ncbi.nlm.nih.gov/pubmed/24586758">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1525 href="https://doi.org/10.1371/journal.pone.0089410">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1529 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3934889">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d12536e1538 class=n-a></a>Seidel K, Siswanto S, Brunt ERP, <i> et al.</i>: Brain pathology of spinocerebellar ataxias. <i>Acta Neuropathol.</i> 2012; <b>124</b>(1): 1–21. <a target=xrefwindow id=d12536e1549 href="http://www.ncbi.nlm.nih.gov/pubmed/22684686">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1552 href="https://doi.org/10.1007/s00401-012-1000-x">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d12536e1562 class=n-a></a>Scherzed W, Brunt ER, Heinsen H, <i> et al.</i>: Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA<sub>2</sub>) and type 3 (SCA<sub>3</sub>). <i>Cerebellum.</i> 2012; <b>11</b>(3): 749–60. <a target=xrefwindow id=d12536e1580 href="http://www.ncbi.nlm.nih.gov/pubmed/22198871">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1583 href="https://doi.org/10.1007/s12311-011-0340-8">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734287980"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e1592 class=n-a></a>Reetz K, Rodríguez-Labrada R, Dogan I, <i> et al.</i>: Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2. <i>Ann Clin Transl Neurol.</i> 2018; <b>5</b>(2): 128–37. <a target=xrefwindow id=d12536e1603 href="http://www.ncbi.nlm.nih.gov/pubmed/29468174">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1606 href="https://doi.org/10.1002/acn3.504">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1610 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5817824">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734287980">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d12536e1623 class=n-a></a>Hernandez-Castillo CR, Galvez V, Mercadillo R, <i> et al.</i>: Extensive White Matter Alterations and Its Correlations with Ataxia Severity in SCA 2 Patients. <i>PLoS One.</i> 2015; <b>10</b>(8): e0135449. <a target=xrefwindow id=d12536e1634 href="http://www.ncbi.nlm.nih.gov/pubmed/26263162">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1637 href="https://doi.org/10.1371/journal.pone.0135449">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1641 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4532454">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d12536e1650 class=n-a></a>Adanyeguh IM, Perlbarg V, Henry PG, <i> et al.</i>: Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes. <i>Neuroimage Clin.</i> 2018; <b>19</b>: 858–67. <a target=xrefwindow id=d12536e1661 href="http://www.ncbi.nlm.nih.gov/pubmed/29922574">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1664 href="https://doi.org/10.1016/j.nicl.2018.06.011">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1668 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6005808">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727487388"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e1677 class=n-a></a>Martins CR Jr, Martinez ARM, de Rezende TJR, <i> et al.</i>: Spinal Cord Damage in Spinocerebellar Ataxia Type 1. <i>Cerebellum.</i> 2017; <b>16</b>(4): 792–6. <a target=xrefwindow id=d12536e1688 href="http://www.ncbi.nlm.nih.gov/pubmed/28386793">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1691 href="https://doi.org/10.1007/s12311-017-0854-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727487388">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d12536e1704 class=n-a></a>Pedroso JL, de Souza PV, Pinto WB, <i> et al.</i>: SCA1 patients may present as hereditary spastic paraplegia and must be included in spastic-ataxias group. <i>Parkinsonism Relat Disord.</i> 2015; <b>21</b>(10): 1243–6. <a target=xrefwindow id=d12536e1715 href="http://www.ncbi.nlm.nih.gov/pubmed/26231471">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1718 href="https://doi.org/10.1016/j.parkreldis.2015.07.015">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d12536e1728 class=n-a></a>Fahl CN, Branco LM, Bergo FP, <i> et al.</i>: Spinal cord damage in Machado-Joseph disease. <i>Cerebellum.</i> 2015; <b>14</b>(2): 128–32. <a target=xrefwindow id=d12536e1739 href="http://www.ncbi.nlm.nih.gov/pubmed/25370748">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1742 href="https://doi.org/10.1007/s12311-014-0619-7">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732910879"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e1751 class=n-a></a>Joers JM, Deelchand DK, Lyu T, <i> et al.</i>: Neurochemical abnormalities in premanifest and early spinocerebellar ataxias. <i>Ann Neurol.</i> 2018; <b>83</b>(4): 816–29. <a target=xrefwindow id=d12536e1762 href="http://www.ncbi.nlm.nih.gov/pubmed/29575033">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1765 href="https://doi.org/10.1002/ana.25212">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1769 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5912959">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732910879">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d12536e1782 class=n-a></a>Adanyeguh IM, Henry PG, Nguyen TM, <i> et al.</i>: <i>In vivo</i> neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. <i>Mov Disord.</i> 2015; <b>30</b>(5): 662–70. <a target=xrefwindow id=d12536e1796 href="http://www.ncbi.nlm.nih.gov/pubmed/25773989">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1800 href="https://doi.org/10.1002/mds.26181">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1803 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4397159">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d12536e1812 class=n-a></a>Cocozza S, Saccà F, Cervo A, <i> et al.</i>: Modifications of resting state networks in spinocerebellar ataxia type 2. <i>Mov Disord.</i> 2015; <b>30</b>(10): 1382–90. <a target=xrefwindow id=d12536e1823 href="http://www.ncbi.nlm.nih.gov/pubmed/26094751">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1826 href="https://doi.org/10.1002/mds.26284">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732610173"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e1835 class=n-a></a>Guell X, Gabrieli JDE, Schmahmann JD: Triple representation of language, working memory, social and emotion processing in the cerebellum: convergent evidence from task and seed-based resting-state fMRI analyses in a single large cohort. <i>Neuroimage.</i> 2018; <b>172</b>: 437–49. <a target=xrefwindow id=d12536e1843 href="http://www.ncbi.nlm.nih.gov/pubmed/29408539">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1846 href="https://doi.org/10.1016/j.neuroimage.2018.01.082">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1849 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5910233">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732610173">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d12536e1862 class=n-a></a>Stefanescu MR, Dohnalek M, Maderwald S, <i> et al.</i>: Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia. <i>Brain.</i> 2015; <b>138</b>(Pt 5): 1182–97. <a target=xrefwindow id=d12536e1873 href="http://www.ncbi.nlm.nih.gov/pubmed/25818870">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1876 href="https://doi.org/10.1093/brain/awv064">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1880 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5963415">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d12536e1890 class=n-a></a>Deistung A, Stefanescu MR, Ernst TM, <i> et al.</i>: Structural and Functional Magnetic Resonance Imaging of the Cerebellum: Considerations for Assessing Cerebellar Ataxias. <i>Cerebellum.</i> 2016; <b>15</b>(1): 21–5. <a target=xrefwindow id=d12536e1901 href="http://www.ncbi.nlm.nih.gov/pubmed/26521073">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1904 href="https://doi.org/10.1007/s12311-015-0738-9">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d12536e1913 class=n-a></a>Duarte JV, Faustino R, Lobo M, <i> et al.</i>: Parametric fMRI of paced motor responses uncovers novel whole-brain imaging biomarkers in spinocerebellar ataxia type 3. <i>Hum Brain Mapp.</i> 2016; <b>37</b>(10): 3656–68. <a target=xrefwindow id=d12536e1924 href="http://www.ncbi.nlm.nih.gov/pubmed/27273236">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1927 href="https://doi.org/10.1002/hbm.23266">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727305821"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e1936 class=n-a></a>Wu C, Chen DB, Feng L, <i> et al.</i>: Oculomotor deficits in spinocerebellar ataxia type 3: Potential biomarkers of preclinical detection and disease progression. <i>CNS Neurosci Ther.</i> 2017; <b>23</b>(4): 321–8. <a target=xrefwindow id=d12536e1947 href="http://www.ncbi.nlm.nih.gov/pubmed/28195427">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1950 href="https://doi.org/10.1111/cns.12676">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727305821">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d12536e1963 class=n-a></a>Raposo M, Vasconcelos J, Bettencourt C, <i> et al.</i>: Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3). <i>BMC Neurol.</i> 2014; <b>14</b>: 17. <a target=xrefwindow id=d12536e1974 href="http://www.ncbi.nlm.nih.gov/pubmed/24450306">PubMed Abstract </a> | <a target=xrefwindow id=d12536e1977 href="https://doi.org/10.1186/1471-2377-14-17">Publisher Full Text </a> | <a target=xrefwindow id=d12536e1981 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3901765">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d12536e1990 class=n-a></a>Moscovich M, Okun MS, Favilla C, <i> et al.</i>: Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. <i>J Neuroophthalmol.</i> 2015; <b>35</b>(1): 16–21. <a target=xrefwindow id=d12536e2001 href="http://www.ncbi.nlm.nih.gov/pubmed/25259863">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2004 href="https://doi.org/10.1097/WNO.0000000000000167">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2008 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4675453">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d12536e2017 class=n-a></a>Velázquez-Pérez L, Rodríguez-Labrada R, Cruz-Rivas EM, <i> et al.</i>: Comprehensive study of early features in spinocerebellar ataxia 2: Delineating the prodromal stage of the disease. <i>Cerebellum.</i> 2014; <b>13</b>(5): 568–79. <a target=xrefwindow id=d12536e2028 href="http://www.ncbi.nlm.nih.gov/pubmed/24906824">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2031 href="https://doi.org/10.1007/s12311-014-0574-3">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d12536e2041 class=n-a></a>Rodríguez-Labrada R, Velázquez-Pérez L, Auburger G, <i> et al.</i>: Spinocerebellar ataxia type 2: Measures of saccade changes improve power for clinical trials. <i>Mov Disord.</i> 2016; <b>31</b>(4): 570–8. <a target=xrefwindow id=d12536e2052 href="http://www.ncbi.nlm.nih.gov/pubmed/26846400">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2055 href="https://doi.org/10.1002/mds.26532">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d12536e2064 class=n-a></a>Cunha-Santos J, Duarte-Neves J, Carmona V, <i> et al.</i>: Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway. <i>Nat Commun.</i> 2016; <b>7</b>: 11445. <a target=xrefwindow id=d12536e2075 href="http://www.ncbi.nlm.nih.gov/pubmed/27165717">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2078 href="https://doi.org/10.1038/ncomms11445">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2082 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4865854">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732321491"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2091 class=n-a></a>Wu YL, Chang JC, Lin WY, <i> et al.</i>: Caffeic acid and resveratrol ameliorate cellular damage in cell and Drosophila models of spinocerebellar ataxia type 3 through upregulation of Nrf2 pathway. <i>Free Radic Biol Med.</i> 2018; <b>115</b>: 309–17. <a target=xrefwindow id=d12536e2102 href="http://www.ncbi.nlm.nih.gov/pubmed/29247688">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2105 href="https://doi.org/10.1016/j.freeradbiomed.2017.12.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732321491">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733137249"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2118 class=n-a></a>Ghorbani Z, Farahani RM, Aliaghaei A, <i> et al.</i>: Resveratrol Protects Purkinje Neurons and Restores Muscle Activity in Rat Model of Cerebellar Ataxia. <i>J Mol Neurosci.</i> 2018; <b>65</b>(1): 35–42. <a target=xrefwindow id=d12536e2129 href="http://www.ncbi.nlm.nih.gov/pubmed/29713949">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2132 href="https://doi.org/10.1007/s12031-018-1065-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733137249">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727801648"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2145 class=n-a></a>Kazachkova N, Raposo M, Ramos A, <i> et al.</i>: Promoter Variant Alters Expression of the Autophagic <i>BECN<sub>1</sub></i> Gene: Implications for Clinical Manifestations of Machado-Joseph Disease. <i>Cerebellum.</i> 2017; <b>16</b>(5–6): 957–63. <a target=xrefwindow id=d12536e2161 href="http://www.ncbi.nlm.nih.gov/pubmed/28699106">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2165 href="https://doi.org/10.1007/s12311-017-0875-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727801648">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733086176"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2178 class=n-a></a>Raposo M, Ramos A, Santos C, <i> et al.</i>: Accumulation of Mitochondrial DNA Common Deletion Since The Preataxic Stage of Machado-Joseph Disease. <i>Mol Neurobiol.</i> 2018; 1–6. <a target=xrefwindow id=d12536e2186 href="http://www.ncbi.nlm.nih.gov/pubmed/29679261">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2189 href="https://doi.org/10.1007/s12035-018-1069-x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733086176">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d12536e2203 class=n-a></a>Pacheco LS, da Silveira AF, Trott A, <i> et al.</i>: Association between Machado-Joseph disease and oxidative stress biomarkers. <i>Mutat Res.</i> 2013; <b>757</b>(2): 99–103. <a target=xrefwindow id=d12536e2214 href="http://www.ncbi.nlm.nih.gov/pubmed/23994570">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2217 href="https://doi.org/10.1016/j.mrgentox.2013.06.023">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732053169"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2226 class=n-a></a>de Assis AM, Saute JAM, Longoni A, <i> et al.</i>: Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease. <i>Front Neurol.</i> 2017; <b>8</b>: 485. <a target=xrefwindow id=d12536e2237 href="http://www.ncbi.nlm.nih.gov/pubmed/28979235">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2240 href="https://doi.org/10.3389/fneur.2017.00485">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2244 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5611390">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732053169">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d12536e2257 class=n-a></a>Evert BO, Schelhaas J, Fleischer H, <i> et al.</i>: Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3. <i>Clin Neuropathol.</i> 2006; <b>25</b>(6): 272–81. <a target=xrefwindow id=d12536e2268 href="http://www.ncbi.nlm.nih.gov/pubmed/17140157">PubMed Abstract </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d12536e2277 class=n-a></a>da Silva Carvalho G, Saute JAM, Haas CB, <i> et al.</i>: Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3. <i>Cerebellum.</i> 2016; <b>15</b>(4): 518–25. <a target=xrefwindow id=d12536e2288 href="http://www.ncbi.nlm.nih.gov/pubmed/26395908">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2291 href="https://doi.org/10.1007/s12311-015-0719-z">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730279808"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2300 class=n-a></a>Raposo M, Bettencourt C, Ramos A, <i> et al.</i>: Promoter Variation and Expression Levels of Inflammatory Genes <i>IL1A</i>, <i>IL1B</i>, <i>IL6</i> and <i>TNF</i> in Blood of Spinocerebellar Ataxia Type 3 (SCA<sub>3</sub>) Patients. <i>Neuromolecular Med.</i> 2017; <b>19</b>(1): 41–5. <a target=xrefwindow id=d12536e2327 href="http://www.ncbi.nlm.nih.gov/pubmed/27246313">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2330 href="https://doi.org/10.1007/s12017-016-8416-8">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730279808">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d12536e2343 class=n-a></a>Zhang H, Wu LM, Wu J: Cross-talk between apolipoprotein E and cytokines. <i>Mediators Inflamm.</i> 2011; <b>2011</b>: 949072. <a target=xrefwindow id=d12536e2351 href="http://www.ncbi.nlm.nih.gov/pubmed/21772670">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2354 href="https://doi.org/10.1155/2011/949072">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2357 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3136159">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733200526"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2367 class=n-a></a>Wilke C, Bender F, Hayer SN, <i> et al.</i>: Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study. <i>J Neurol.</i> 2018; <b>265</b>(7): 1618–24. <a target=xrefwindow id=d12536e2378 href="http://www.ncbi.nlm.nih.gov/pubmed/29737427">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2381 href="https://doi.org/10.1007/s00415-018-8893-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733200526">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d12536e2394 class=n-a></a>Menke RA, Gray E, Lu CH, <i> et al.</i>: CSF neurofilament light chain reflects corticospinal tract degeneration in ALS. <i>Ann Clin Transl Neurol.</i> 2015; <b>2</b>(7): 748–55. <a target=xrefwindow id=d12536e2405 href="http://www.ncbi.nlm.nih.gov/pubmed/26273687">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2408 href="https://doi.org/10.1002/acn3.212">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2412 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4531057">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d12536e2421 class=n-a></a>Byrne LM, Rodrigues FB, Blennow K, <i> et al.</i>: Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis. <i>Lancet Neurol.</i> 2017; <b>16</b>(8): 601–9. <a target=xrefwindow id=d12536e2432 href="http://www.ncbi.nlm.nih.gov/pubmed/28601473">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2435 href="https://doi.org/10.1016/S1474-4422(17)30124-2">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2439 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5507767">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732451556"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2448 class=n-a></a>Rossi D, Volanti P, Brambilla L, <i> et al.</i>: CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis. <i>J Neurol.</i> 2018; <b>265</b>(3): 510–21. <a target=xrefwindow id=d12536e2459 href="http://www.ncbi.nlm.nih.gov/pubmed/29322259">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2462 href="https://doi.org/10.1007/s00415-017-8730-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732451556">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d12536e2475 class=n-a></a>Brouillette AM, Öz G, Gomez CM: Cerebrospinal Fluid Biomarkers in Spinocerebellar Ataxia: A Pilot Study. <i>Dis Markers.</i> 2015; <b>2015</b>: 413098. <a target=xrefwindow id=d12536e2483 href="http://www.ncbi.nlm.nih.gov/pubmed/26265793">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2486 href="https://doi.org/10.1155/2015/413098">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2489 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4525756">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d12536e2498 class=n-a></a>Bürk K, Globas C, Bösch S, <i> et al.</i>: Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. <i>J Neurol.</i> 2003; <b>250</b>(2): 207–11. <a target=xrefwindow id=d12536e2509 href="http://www.ncbi.nlm.nih.gov/pubmed/12574952">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2512 href="https://doi.org/10.1007/s00415-003-0976-5">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d12536e2522 class=n-a></a>Moriarty A, Cook A, Hunt H, <i> et al.</i>: A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7. <i>Orphanet J Rare Dis.</i> 2016; <b>11</b>(1): 82. <a target=xrefwindow id=d12536e2533 href="http://www.ncbi.nlm.nih.gov/pubmed/27333979">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2536 href="https://doi.org/10.1186/s13023-016-0447-6">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2540 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4917932">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d12536e2549 class=n-a></a>Jacobi H, du Montcel ST, Bauer P, <i> et al.</i>: Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias. <i>J Neurol.</i> 2018; <b>265</b>(9): 2040–51. <a target=xrefwindow id=d12536e2560 href="http://www.ncbi.nlm.nih.gov/pubmed/29959555">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2563 href="https://doi.org/10.1007/s00415-018-8954-0">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d12536e2572 class=n-a></a>Fancellu R, Paridi D, Tomasello C, <i> et al.</i>: Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2. <i>J Neurol.</i> 2013; <b>260</b>(12): 3134–43. <a target=xrefwindow id=d12536e2583 href="http://www.ncbi.nlm.nih.gov/pubmed/24122064">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2586 href="https://doi.org/10.1007/s00415-013-7138-1">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727410402"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2595 class=n-a></a>Pereira L, Airan RD, Fishman A, <i> et al.</i>: Resting-state functional connectivity and cognitive dysfunction correlations in spinocerebelellar ataxia type 6 (SCA6). <i>Hum Brain Mapp.</i> 2017; <b>38</b>(6): 3001–10. <a target=xrefwindow id=d12536e2606 href="http://www.ncbi.nlm.nih.gov/pubmed/28295805">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2609 href="https://doi.org/10.1002/hbm.23568">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727410402">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732228677"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2622 class=n-a></a>Hoche F, Guell X, Vangel MG, <i> et al.</i>: The cerebellar cognitive affective/Schmahmann syndrome scale. <i>Brain.</i> 2018; <b>141</b>(1): 248–70. <a target=xrefwindow id=d12536e2633 href="http://www.ncbi.nlm.nih.gov/pubmed/29206893">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2636 href="https://doi.org/10.1093/brain/awx317">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2640 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5837248">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732228677">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d12536e2653 class=n-a></a>Gennarino VA, Singh RK, White JJ, <i> et al.</i>: <i>Pumilio1</i> haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels. <i>Cell.</i> 2015; <b>160</b>(6): 1087–98. <a target=xrefwindow id=d12536e2667 href="http://www.ncbi.nlm.nih.gov/pubmed/25768905">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2671 href="https://doi.org/10.1016/j.cell.2015.02.012">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2674 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4383046">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732739901"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2684 class=n-a></a>Gennarino VA, Palmer EE, McDonell LM, <i> et al.</i>: A Mild <i>PUM1</i> Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures. <i>Cell.</i> 2018; <b>172</b>(5): 924–936.e11. <a target=xrefwindow id=d12536e2698 href="http://www.ncbi.nlm.nih.gov/pubmed/29474920">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2702 href="https://doi.org/10.1016/j.cell.2018.02.006">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2705 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5832058">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732739901">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732014940"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2718 class=n-a></a>Nibbeling EAR, Duarri A, Verschuuren-Bemelmans CC, <i> et al.</i>: Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia. <i>Brain.</i> 2017; <b>140</b>(11): 2860–78. <a target=xrefwindow id=d12536e2729 href="http://www.ncbi.nlm.nih.gov/pubmed/29053796">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2732 href="https://doi.org/10.1093/brain/awx251">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732014940">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d12536e2745 class=n-a></a>Coutelier M, Coarelli G, Monin ML, <i> et al.</i>: A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies. <i>Brain.</i> 2017; <b>140</b>(6): 1579–94. <a target=xrefwindow id=d12536e2756 href="http://www.ncbi.nlm.nih.gov/pubmed/28444220">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2759 href="https://doi.org/10.1093/brain/awx081">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d12536e2768 class=n-a></a>Coutelier M, Blesneac I, Monteil A, <i> et al.</i>: A Recurrent Mutation in <i>CACNA1G</i> Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia. <i>Am J Hum Genet.</i> 2015; <b>97</b>(5): 726–37. <a target=xrefwindow id=d12536e2782 href="http://www.ncbi.nlm.nih.gov/pubmed/26456284">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2786 href="https://doi.org/10.1016/j.ajhg.2015.09.007">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2789 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4667105">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d12536e2798 class=n-a></a>Kimura M, Yabe I, Hama Y, <i> et al.</i>: SCA42 mutation analysis in a case series of Japanese patients with spinocerebellar ataxia. <i>J Hum Genet.</i> 2017; <b>62</b>(9): 857–9. <a target=xrefwindow id=d12536e2809 href="http://www.ncbi.nlm.nih.gov/pubmed/28490766">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2812 href="https://doi.org/10.1038/jhg.2017.51">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d12536e2821 class=n-a></a>Chemin J, Siquier-Pernet K, Nicouleau M, <i> et al.</i>: <i>De novo</i> mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the <i>CACNA1G</i> calcium channel gene. <i>Brain.</i> 2018; <b>141</b>(7): 1998–2013. <a target=xrefwindow id=d12536e2839 href="http://www.ncbi.nlm.nih.gov/pubmed/29878067">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2842 href="https://doi.org/10.1093/brain/awy145">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730924831"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2852 class=n-a></a>Watson LM, Bamber E, Schnekenberg RP, <i> et al.</i>: Dominant Mutations in <i>GRM1</i> Cause Spinocerebellar Ataxia Type 44. <i>Am J Hum Genet.</i> 2017; <b>101</b>(3): 451–458. <a target=xrefwindow id=d12536e2866 href="http://www.ncbi.nlm.nih.gov/pubmed/28886343">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2870 href="https://doi.org/10.1016/j.ajhg.2017.08.005">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2873 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5591020">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730924831">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d12536e2886 class=n-a></a>Jiang T, Tan MS, Tan L, <i> et al.</i>: Application of next-generation sequencing technologies in Neurology. <i>Ann Transl Med.</i> 2014; <b>2</b>(12): 125. <a target=xrefwindow id=d12536e2897 href="http://www.ncbi.nlm.nih.gov/pubmed/25568878">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2900 href="https://doi.org/10.3978/j.issn.2305-5839.2014.11.11">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2904 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4260045">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/722811618"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2913 class=n-a></a>Lee H, Deignan JL, Dorrani N, <i> et al.</i>: Clinical exome sequencing for genetic identification of rare Mendelian disorders. <i>JAMA.</i> 2014; <b>312</b>(18): 1880–7. <a target=xrefwindow id=d12536e2924 href="http://www.ncbi.nlm.nih.gov/pubmed/25326637">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2927 href="https://doi.org/10.1001/jama.2014.14604">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2931 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4278636">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/722811618">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726569394"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2944 class=n-a></a>Shuvaev AN, Hosoi N, Sato Y, <i> et al.</i>: Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice. <i>J Physiol.</i> 2017; <b>595</b>(1): 141–64. <a target=xrefwindow id=d12536e2955 href="http://www.ncbi.nlm.nih.gov/pubmed/27440721">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2958 href="https://doi.org/10.1113/JP272950">Publisher Full Text </a> | <a target=xrefwindow id=d12536e2962 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5199750">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726569394">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726334898"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2975 class=n-a></a>Power EM, Morales A, Empson RM: Prolonged Type 1 Metabotropic Glutamate Receptor Dependent Synaptic Signaling Contributes to Spino-Cerebellar Ataxia Type 1. <i>J Neurosci.</i> 2016; <b>36</b>(18): 4910–6. <a target=xrefwindow id=d12536e2983 href="http://www.ncbi.nlm.nih.gov/pubmed/27147646">PubMed Abstract </a> | <a target=xrefwindow id=d12536e2986 href="https://doi.org/10.1523/JNEUROSCI.3953-15.2016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726334898">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732883577"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e2999 class=n-a></a>Bushart DD, Chopra R, Singh V, <i> et al.</i>: Targeting potassium channels to treat cerebellar ataxia. <i>Ann Clin Transl Neurol.</i> 2018; <b>5</b>(3): 297–314. <a target=xrefwindow id=d12536e3010 href="http://www.ncbi.nlm.nih.gov/pubmed/29560375">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3013 href="https://doi.org/10.1002/acn3.527">Publisher Full Text </a> | <a target=xrefwindow id=d12536e3017 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5846455">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732883577">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732796809"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e3031 class=n-a></a>Ishiura H, Doi K, Mitsui J, <i> et al.</i>: Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy. <i>Nat Genet.</i> 2018; <b>50</b>(4): 581–90. <a target=xrefwindow id=d12536e3042 href="http://www.ncbi.nlm.nih.gov/pubmed/29507423">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3045 href="https://doi.org/10.1038/s41588-018-0067-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732796809">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d12536e3058 class=n-a></a>Zesiewicz TA, Wilmot G, Kuo SH, <i> et al.</i>: Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. <i>Neurology.</i> 2018; <b>90</b>(10): 464–71. <a target=xrefwindow id=d12536e3069 href="http://www.ncbi.nlm.nih.gov/pubmed/29440566">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3072 href="https://doi.org/10.1212/WNL.0000000000005055">Publisher Full Text </a> | <a target=xrefwindow id=d12536e3076 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5863491">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d12536e3085 class=n-a></a>Romano S, Coarelli G, Marcotulli C, <i> et al.</i>: Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial. <i>Lancet Neurol.</i> 2015; <b>14</b>(10): 985–91. <a target=xrefwindow id=d12536e3096 href="http://www.ncbi.nlm.nih.gov/pubmed/26321318">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3099 href="https://doi.org/10.1016/S1474-4422(15)00201-X">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d12536e3108 class=n-a></a>Lei LF, Yang GP, Wang JL, <i> et al.</i>: Safety and efficacy of valproic acid treatment in SCA<sub>3</sub>/MJD patients. <i>Parkinsonism Relat Disord.</i> 2016; <b>26</b>: 55–61. <a target=xrefwindow id=d12536e3122 href="http://www.ncbi.nlm.nih.gov/pubmed/26997655">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3126 href="https://doi.org/10.1016/j.parkreldis.2016.03.005">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731736884"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e3135 class=n-a></a>Manes M, Alberici A, Di Gregorio E, <i> et al.</i>: Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38. <i>Ann Neurol.</i> 2017; <b>82</b>(4): 615–21. <a target=xrefwindow id=d12536e3146 href="http://www.ncbi.nlm.nih.gov/pubmed/28976605">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3149 href="https://doi.org/10.1002/ana.25059">Publisher Full Text </a> | <a target=xrefwindow id=d12536e3153 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5698802">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731736884">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d12536e3166 class=n-a></a>Keiser MS, Kordasiewicz HB, McBride JL: Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia. <i>Hum Mol Genet.</i> 2016; <b>25</b>(R1): R53–64. <a target=xrefwindow id=d12536e3174 href="http://www.ncbi.nlm.nih.gov/pubmed/26503961">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3177 href="https://doi.org/10.1093/hmg/ddv442">Publisher Full Text </a> | <a target=xrefwindow id=d12536e3180 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4802374">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d12536e3190 class=n-a></a>Matos CA, de Almeida LP, Nóbrega C: Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy. <i>J Neurochem.</i> 2018. <a target=xrefwindow id=d12536e3195 href="http://www.ncbi.nlm.nih.gov/pubmed/29959858">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3198 href="https://doi.org/10.1111/jnc.14541">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727503963"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e3207 class=n-a></a>Scoles DR, Meera P, Schneider MD, <i> et al.</i>: Antisense oligonucleotide therapy for spinocerebellar ataxia type 2. <i>Nature.</i> 2017; <b>544</b>(7650): 362–6. <a target=xrefwindow id=d12536e3218 href="http://www.ncbi.nlm.nih.gov/pubmed/28405024">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3221 href="https://doi.org/10.1038/nature22044">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727503963">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727724361"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e3234 class=n-a></a>Moore LR, Rajpal G, Dillingham IT, <i> et al.</i>: Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models. <i>Mol Ther Nucleic Acids.</i> 2017; <b>7</b>: 200–10. <a target=xrefwindow id=d12536e3245 href="http://www.ncbi.nlm.nih.gov/pubmed/28624196">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3248 href="https://doi.org/10.1016/j.omtn.2017.04.005">Publisher Full Text </a> | <a target=xrefwindow id=d12536e3252 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5415970">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727724361">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733458894"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e3265 class=n-a></a>McLoughlin HS, Moore LR, Chopra R, <i> et al.</i>: Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice. <i>Ann Neurol.</i> 2018; <b>84</b>(1): 64–77. <a target=xrefwindow id=d12536e3276 href="http://www.ncbi.nlm.nih.gov/pubmed/29908063">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3279 href="https://doi.org/10.1002/ana.25264">Publisher Full Text </a> | <a target=xrefwindow id=d12536e3283 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6119475">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733458894">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731217459"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e3296 class=n-a></a>Toonen LJA, Rigo F, van Attikum H, <i> et al.</i>: Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice. <i>Mol Ther Nucleic Acids.</i> 2017; <b>8</b>: 232–42. <a target=xrefwindow id=d12536e3307 href="http://www.ncbi.nlm.nih.gov/pubmed/28918024">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3310 href="https://doi.org/10.1016/j.omtn.2017.06.019">Publisher Full Text </a> | <a target=xrefwindow id=d12536e3314 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5504086">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731217459">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d12536e3327 class=n-a></a>Skotte NH, Southwell AL, Østergaard ME, <i> et al.</i>: Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients. <i>PLoS One.</i> 2014; <b>9</b>(9): e107434. <a target=xrefwindow id=d12536e3338 href="http://www.ncbi.nlm.nih.gov/pubmed/25207939">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3341 href="https://doi.org/10.1371/journal.pone.0107434">Publisher Full Text </a> | <a target=xrefwindow id=d12536e3345 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4160241">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731220229"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e3355 class=n-a></a>Wild EJ, Tabrizi SJ: Therapies targeting DNA and RNA in Huntington's disease. <i>Lancet Neurol.</i> 2017; <b>16</b>(10): 837–47. <a target=xrefwindow id=d12536e3363 href="http://www.ncbi.nlm.nih.gov/pubmed/28920889">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3366 href="https://doi.org/10.1016/S1474-4422(17)30280-6">Publisher Full Text </a> | <a target=xrefwindow id=d12536e3369 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5604739">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731220229">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732062321"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e3382 class=n-a></a>Finkel RS, Mercuri E, Darras BT, <i> et al.</i>: Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. <i>N Engl J Med.</i> 2017; <b>377</b>(18): 1723–32. <a target=xrefwindow id=d12536e3393 href="http://www.ncbi.nlm.nih.gov/pubmed/29091570">PubMed Abstract </a> | <a target=xrefwindow id=d12536e3396 href="https://doi.org/10.1056/NEJMoa1702752">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732062321">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734287984"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12536e3409 class=n-a></a>Mercuri E, Finkel R, Kirschner J, <i> et al.</i>: Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): End of study results from the phase 3 CHERISH study. <i>Neuromuscular Disorders.</i> 2017; <b>27</b>(2): S210. <a target=xrefwindow id=d12536e3420 href="https://doi.org/10.1016/j.nmd.2017.06.418">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734287984">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 12 Nov 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1781.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1781.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Assistance Publique-Ho&#770;pitaux de Paris (AP-HP), Department of Neurology, Avicenne Hospital, Paris 13 University, Bobigny, 93000, France<br/> <sup>2</sup> Institut du Cerveau et de la Moelle &eacute;pini&egrave;re, ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne University, Paris, 75013, France<br/> <sup>3</sup> Assistance Publique-Ho&#770;pitaux de Paris (AP-HP), Genetic department, Piti&eacute;-Salp&ecirc;tri&egrave;re University Hospital, Paris, 75013, France<br/> <p> <div class=margin-bottom> Giulia Coarelli <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Alexis Brice <br/> <span>Roles: </span> Supervision, Validation, Writing – Review & Editing </div> <div class=margin-bottom> Alexandra Durr <br/> <span>Roles: </span> Conceptualization, Supervision, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1781/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 12 Nov 2018, 7:1781 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.15788.1">https://doi.org/10.12688/f1000research.15788.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Coarelli G <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=17234 data-id=15788 data-downloads="" data-views="" data-scholar="10.12688/f1000research.15788.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1781/v1/pdf?article_uuid=1115b648-e99f-41fb-93f1-f9d8bba08461" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.15788.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Coarelli G, Brice A and Durr A. Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view [version 1; peer review: 3 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1781 (<a href="https://doi.org/10.12688/f1000research.15788.1" target=_blank>https://doi.org/10.12688/f1000research.15788.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=15788 id=mobile-track-article-signin-15788 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/15788?target=/articles/7-1781.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17234 /> <input name=articleId type=hidden value=15788 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Harry Orr</strong>, Institute for Translational Neuroscience, University of Minnesota, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Bing-wen Soong</strong>, Department of Neurology, Shuang Ho Hospital, Taipei Medical University, Taiwan </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Vikram G Shakkottai</strong>, Department of Neurology, University of Michigan, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 12 Nov 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1781.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1781.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=41232-40146></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=41233-40148></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=41234-40147></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1781/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>12 Nov 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Harry Orr</strong>, Institute for Translational Neuroscience, University of Minnesota, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Bing-wen Soong</strong>, Department of Neurology, Shuang Ho Hospital, Taipei Medical University, Taiwan </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Vikram G Shakkottai</strong>, Department of Neurology, University of Michigan, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1781.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1781/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding dominant...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1781/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1781/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1781/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Coarelli G et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1781/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1781",
            templates : {
                twitter : "Recent advances in understanding dominant spinocerebellar ataxias.... Coarelli G et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1781/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/15788/17234")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "17234");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "40146": 0,
                           "40147": 0,
                           "40148": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "b185f84c-eae4-4987-ba4b-7d3d562fdb61";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1781.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1781.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1781.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1781.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1781.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>